Autoantibodies Against Perilipin 1 as a Cause of Acquired Generalized Lipodystrophy

Overview of attention for article published in Frontiers in immunology, September 2018

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
Good Attention Score compared to outputs of the same age (72nd percentile)
Good Attention Score compared to outputs of the same age and source (78th percentile)

Mentioned by

patent: 3 patents

facebook: 1 Facebook page

Citations

dimensions_citation: 26 Dimensions

Readers on

mendeley: 35 Mendeley

Summary Patents Facebook Dimensions citations

So far, Altmetric has seen 3 patents that reference this research output.

AUTOANTIBODIES AS BIOMARKERS FOR LIPODYSTROPHY

Application WO-2022146837-A1

World Intellectual Property Organisation (WIPO)

MEANS FOR SPECIFICALLY ELIMINATING PERILIPIN-1 FRAGMENT PRESENTING ADIPOCYTES

Application WO-2020165366-A1

World Intellectual Property Organisation (WIPO)

MEANS FOR SPECIFICALLY ELIMINATING PERILIPIN-1 FRAGMENT PRESENTING ADIPOCYTES

Application EP-3695883-A1

European Patent Office

This page shows the most recent patents that mention this research output.

Click here to find out how to access more activity.